Create Health
1 – 10 of 1017
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
(
- Contribution to journal › Article
-
Mark
Altered immune signatures in breast cancer lymph nodes with metastases revealed by spatial proteome analyses
(
- Contribution to journal › Article
-
Mark
The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue
(
- Contribution to journal › Article
-
Mark
In vitro characterisation of a novel rubber contact allergen in protective gloves
(
- Contribution to journal › Article
- 2024
-
Mark
WOMBAT-P : Benchmarking Label-Free Proteomics Data Analysis Workflows
(
- Contribution to journal › Article
-
Mark
Identification of Quantitative Trait Nucleotides and Development of Diagnostic Markers for Nine Fatty Acids in the Peanut
(
- Contribution to journal › Article
-
Mark
An introduction to recent approaches underlying mechanistic insights harboring oncobiology
2024) p.3-47(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases : Mariana Reste1† , Kristi Ajazi 2† , Ayca Sayi-Yazgan3,4, Radmila Jankovic 5 , Biljana Bufan6 , Sven Brandau7 , Espen S. Bækkevold 8 , Florent Petitprez 9 , Malin Lindstedt 2 *, Gosse J. Adema10* and Catarina R. Almeida1 *
(
- Contribution to journal › Article
-
Mark
Automated multiplexed affinity-based enrichment of peptides for LC-MS/MS plasma proteomics
(
- Contribution to journal › Article
-
Mark
Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
(
- Contribution to journal › Article